MAP Medical Technologies Overview
- Year Founded
-
1991
- Status
-
Acquired/Merged
- Employees
-
69
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
2
MAP Medical Technologies General Information
Description
Manufacturer of radiopharmaceuticals based in Tikkakoski, Finland. The company specializes in PET (positron emission tomography) and SPECT (single, photon emission computed tomography) products, which serve the needs of nuclear medicine professionals across Nordics and Baltics.
Contact Information
Website
www.mapmedical.fiCorporate Office
- Elementtitie 27
- 41160 Tikkakoski
- Finland
Corporate Office
- Elementtitie 27
- 41160 Tikkakoski
- Finland
MAP Medical Technologies Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
MAP Medical Technologies Comparisons
Industry
Financing
Details
MAP Medical Technologies Competitors (2)
One of MAP Medical Technologies’s 2 competitors is Medi-Radiopharma Co., a Corporation company based in Erd, Hungary.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Medi-Radiopharma Co. | Corporation | Erd, Hungary | ||||
| SAM Nordic | Corporation | Nacka, Sweden |
MAP Medical Technologies Patents
MAP Medical Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2002246164-A1 | Use of cationic dextran derivatives for protecting dose-limiting organs | Inactive | 11-Apr-2001 | ||
| CA-2443052-A1 | Use of cationic dextran derivatives for protecting dose-limiting organs | Inactive | 11-Apr-2001 | ||
| EP-1383517-A1 | Use of cationic dextran derivatives for protecting dose-limiting organs | Inactive | 11-Apr-2001 | ||
| WO-2002083154-A1 | Use of cationic dextran derivatives for protecting dose-limiting organs | Inactive | 11-Apr-2001 | ||
| ES-2232947-T3 | Procedure for the production of neurorecepeptive agents marked with radioactic iodine. | Inactive | 16-Jun-1997 | C07D451/02 |
MAP Medical Technologies Signals
MAP Medical Technologies Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
MAP Medical Technologies FAQs
-
When was MAP Medical Technologies founded?
MAP Medical Technologies was founded in 1991.
-
Where is MAP Medical Technologies headquartered?
MAP Medical Technologies is headquartered in Tikkakoski, Finland.
-
What is the size of MAP Medical Technologies?
MAP Medical Technologies has 69 total employees.
-
What industry is MAP Medical Technologies in?
MAP Medical Technologies’s primary industry is Pharmaceuticals.
-
Is MAP Medical Technologies a private or public company?
MAP Medical Technologies is a Private company.
-
What is MAP Medical Technologies’s current revenue?
The current revenue for MAP Medical Technologies is .
-
Who are MAP Medical Technologies’s investors?
Schering-Plough has invested in MAP Medical Technologies.
-
Who are MAP Medical Technologies’s competitors?
Medi-Radiopharma Co. and SAM Nordic are competitors of MAP Medical Technologies.
-
When was MAP Medical Technologies acquired?
MAP Medical Technologies was acquired on 02-Dec-2019.
-
Who acquired MAP Medical Technologies?
MAP Medical Technologies was acquired by Curium Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process